Yun, Cheolmin <br/><br/>
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration.  [electronic resource] 

 -  BMC ophthalmology  Mar 2016 
 - 25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2415 
<br/><br/><label>Standard No.: </label>10.1186/s12886-016-0203-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--therapeutic use<br/>Choroid--pathology<br/>Female<br/>Fluorescein Angiography<br/>Humans<br/>Intravitreal Injections<br/>Male<br/>Middle Aged<br/>Organ Size<br/>Ranibizumab--therapeutic use<br/>Refraction, Ocular--physiology<br/>Tomography, Optical Coherence<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology<br/>Wet Macular Degeneration--drug therapy